Our unique approach ensures our portfolio companies are creating game changing revolutionary science, actively building collaborative working relationships with our companies to help them grow. As a result, we don’t just invest, we partner to enable disruptive scientific changes helping patients live better lives.
The Alpine BioVentures team has relationships with leading research labs in the US and around the world to find bold scientific ideas with the potential to help people living with cancer, autoimmune conditions, and orphan diseases. We license innovative technologies and work with the scientific inventors to create game changing companies meaningfully impacting patients’ lives.
Alpine BioVentures works with other venture funds to grow our portfolio of privately-held companies with bold science into important companies in our industry. We leverage our decades of experience to help focus research, development, and partnering activities to to get new science to patients faster.
Alpine BioVentures invests in scientific ideas so bold or game changing they make typical investors uncomfortable. These misvalued companies and scientific ideas are where we thrive. We led the approval of the world’s first cancer immunotherapy when many thought that was an impossible task. We enable great science through our active involvement and investment.
Identify an area of unmet scientific need
Locate the best science and scientists to solve the problem
Seed with sufficient capital to achieve proof of concept
Establish management and scientific advisiors
Drive science to proof of concept
Secure added capital
Drive liquidity